Hey everyone, I've been digging into these newer peptides lately because last year I finally got serious about dropping the extra weight that crept on during remote work and endless zoom calls. I started with one of the dual-agonist options (you know, the GLP-1 + GIP kind), and it definitely helped curb my appetite and steady out my energy, but I'm curious how the triple-agonist versions stack up in actual metabolic experiments or real-user reports. Like, does hitting that extra glucagon pathway really push fat loss further or improve things like liver fat and energy burn in noticeable ways compared to the dual ones? Anyone tried both or seen solid data side-by-side? Would love to hear thoughts since I'm debating if it's worth waiting or switching.